E. Schrinner
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Antibiotic Resistance in Bacteria 18
- Pharmacology 24
- Antibiotics Pharmacokinetics and Efficacy 21
- Co-authors
- Michael Limbert (23 shared papers)Gerhard Seibert (24 shared papers)NORBERT KLESEL (20 shared papers)Irvin Winkler (10 shared papers)A. Markus (9 shared papers)Karlheinz Seeger (4 shared papers)Helga Rübsamen‐Waigmann (2 shared papers)Christoph Meichsner (2 shared papers)
In The Last Decade
E. Schrinner
33 papers receiving 466 citations
Peers
Comparison fields: 5 of 73
- Molecular Medicine 249
- Pharmacology 343
- Microbiology 44
- Infectious Diseases 117
- Clinical Biochemistry 43
Countries citing papers authored by E. Schrinner
This map shows the geographic impact of E. Schrinner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Schrinner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Schrinner more than expected).
Fields of papers citing papers by E. Schrinner
This network shows the impact of papers produced by E. Schrinner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Schrinner. The network helps show where E. Schrinner may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Schrinner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 98 | |
| 2 | 1977 | 64 | |
| 3 | 1980 | 43 | |
| 4 | 1988 | 34 | |
| 5 | 1984 | 32 | |
| 6 | 1988 | 28 | |
| 7 | 1992 | 26 | |
| 8 | 1984 | 24 | |
| 9 | 1984 | 23 | |
| 10 | 1984 | 23 | |
| 11 | 1982 | 21 | |
| 12 | 1987 | 19 | |
| 13 | 1992 | 15 | |
| 14 | [Microbiological laboratory studies with ciclopiroxolamine (author's transl)]. | 1981 | 13 |
| 15 | 1992 | 12 | |
| 16 | [The Candida infected hen's egg. An alternative test system for systemic anticandida activity]. | 1995 | 11 |
| 17 | 1987 | 10 | |
| 18 | The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams. | 1984 | 10 |
| 19 | 1984 | 10 | |
| 20 | [The antibacterial activity in vitro of ofloxacin in comparison with other orally administered antimicrobial substances on ampicillin-resistant clinical isolates]. | 1984 | 8 |
About E. Schrinner
E. Schrinner is a scholar working on Molecular Medicine, Pharmacology, Infectious Diseases, Applied Microbiology and Biotechnology and Clinical Biochemistry, having authored 36 papers that have together received 577 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (21 papers), Antibiotic Resistance in Bacteria (18 papers), Phenothiazines and Benzothiazines Synthesis and Activities (7 papers), Antimicrobial Resistance in Staphylococcus (5 papers), HIV/AIDS drug development and treatment (3 papers), Bacterial Identification and Susceptibility Testing (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Antibiotic Use and Resistance (3 papers). The work is most often cited by research in Molecular Medicine (249 citations), Pharmacology (343 citations), Microbiology (44 citations), Infectious Diseases (117 citations) and Clinical Biochemistry (43 citations). E. Schrinner has collaborated with scholars based in Germany and Croatia. Frequent co-authors include Michael Limbert, Gerhard Seibert, NORBERT KLESEL, Irvin Winkler, A. Markus, Karlheinz Seeger, Helga Rübsamen‐Waigmann, Christoph Meichsner, Jürgen Blumbach and H. U. Schorlemmer. Their work appears in journals such as The Journal of Antibiotics, Journal of Antimicrobial Chemotherapy, Infection, Antimicrobial Agents and Chemotherapy and AIDS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.